Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 12, 2023

SELL
$2.68 - $4.79 $35,376 - $63,228
-13,200 Reduced 50.97%
12,700 $1,000
Q4 2022

Feb 14, 2023

BUY
$1.22 - $2.85 $31,598 - $73,815
25,900 New
25,900 $6,000
Q4 2021

Feb 14, 2022

SELL
$0.86 - $1.7 $17,286 - $34,170
-20,100 Reduced 48.32%
21,500 $6,000
Q2 2021

Aug 11, 2021

BUY
$6.55 - $8.98 $272,480 - $373,568
41,600 New
41,600 $20,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $864M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.